Bumetrizole

Bumetrizole

SCHEMBL2398487

Cc1cc(-n2nc3ccc(Cl)cc3n2)c(O)c(C(C)(C)C)c1.Cc1cc(-n2nc3ccc(Cl)cc3n2)c(O)c(C(C)(C)C)c1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.53
RAB9A P51151 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 4/20 0.44
POLB P06746 2/20 0.44
CA2 P00918 1/20 0.44
TYR P14679 1/20 0.44
LMNA P02545 1/20 0.40
HSPA5 P11021 1/20 0.38
CYP2C9 P11712 4/20 0.37
CYP2C19 P33261 4/20 0.37
HIF1A Q16665 3/20 0.37
MAPT P10636 4/20 0.35
KDM4E B2RXH2 3/20 0.35
ATM Q13315 2/20 0.35
CYP1A2 P05177 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP2D6 P10635 1/20 0.34
TP53 P04637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bumetrizole SCHEMBL8603228 1.00 NPC1 (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
Bumetrizole SCHEMBL8054070 1.00 NPC1 (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
Bumetrizole SCHEMBL23734 1.00 NPC1 (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
Bumetrizole SCHEMBL8056551 1.00 NPC1 (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
Bumetrizole SCHEMBL29353083 1.00 NPC1 (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
Bumetrizole SCHEMBL10836210 0.99 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
Bumetrizole SCHEMBL6029618 0.99 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
Bumetrizole SCHEMBL9273939 0.99 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
Bumetrizole SCHEMBL9301984 0.99 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
Bumetrizole SCHEMBL6068328 0.96 NPC1 (0.60) NPC1RAB9ASMN1; SMN2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024053449-A1 PHOTOCHROMIC PARTICLE AQUEOUS DISPERSION AND WATER-BASED INK COMPOSITION CONTAINING SAME 三菱鉛筆株式会社 2024-03-14 WO disclosed
US-11364710-B2 Composition, film, glass article, compound, high purity composition, method for producing compound, and method for producing film FUJIFILM CORPORATION (JP) 2022-06-21 US disclosed
EP-3636612-A1 METHOD FOR REUSING INTERMEDIATE FILM FOR LAMINATED GLASS Kuraray Co., Ltd. (JP) 2020-04-15 EP disclosed
CN-105164175-B Polyurethane, product and coating prepared therefrom and its manufacturing method PPG工业俄亥俄公司 2019-06-04 CN disclosed
EP-3404055-A1 COMPOSITION, FILM, GLASS ARTICLE, COMPOUND, HIGH PURITY COMPOSITION, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING FILM FUJIFILM Corporation (JP) 2018-11-21 EP disclosed
US-20180311936-A1 COMPOSITION, FILM, GLASS ARTICLE, COMPOUND, HIGH PURITY COMPOSITION, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING FILM FUJIFILM CORPORATION (JP) 2018-11-01 US disclosed
CN-105308136-B Fast curing aspartate polysiloxane hybrid coating 科思创有限公司 2018-09-18 CN disclosed
CN-105031743-B Recycled resin composition and the disposable medical instrument being produced from it 贝克顿·迪金森公司 2018-06-26 CN disclosed
CN-108178876-A Recycled resin composition and the disposable medical equipment being produced from it 贝克顿·迪金森公司 2018-06-19 CN disclosed
EP-2697237-B1 PLASTICIZERS AND OPTICAL FILMS MERCK PATENT GMBH (DE) 2016-03-02 EP disclosed
US-5250606-A Polymer blend compositions containing a styrenic copolymer, an acetal polymer and a thermoplastic polyester or polycarbonate resin ingredient THE DOW CHEMICAL COMPANY (US) 1993-10-05 US disclosed
US-5244946-A Styrenic copolymer/polyacetal/thermoplastic polyurethane or elastomeric copolyester blend compositions THE DOW CHEMICAL COMPANY (US) 1993-09-14 US disclosed
US-5196461-A Molding material THE DOW CHEMICAL COMPANY (US) 1993-03-23 US disclosed
US-5061558-A METHACRYLATE PROTECTIVE COATING CONTAINING A UV-ABSORBER FOR POLYCARBONATE ROHM GMBH CHEMISCHE FABRIK (DE) 1991-10-29 US disclosed
US-5025050-A Including a 2-(2-hydroxyphenyl)benzotriazole, and a titanate ETHYL CORPORATION (US) 1991-06-18 US disclosed
US-5021485-A Light stabilizer combination CIBA-GEIGY CORPORATION (US) 1991-06-04 US disclosed
US-4740542-A Stabilization of high solids coatings with synergistic combinations AMERICAN CYANAMID COMPANY (US) 1988-04-26 US disclosed
US-4619956-A MIXTURE OF PIPERDINE AND TRIAZINE COMPOUNDS AMERICAN CYANAMID CO. (US) 1986-10-28 US disclosed
US-4525504-A 1,4-CYCLOHEXANDEICARBOXYLIC ACID AND 2,2,4,4-TETRAMETHYL-1,3-CYCLOBUTANEDIOL, UV AND HINDERED AMINE STABILIZERS EASTMAN KODAK COMPANY (US) 1985-06-25 US disclosed
US-4524165-A 1,4-CYCLOHEXANEDICARBOXYLIC ACID AND 1,4-CYCLOHEXANE DIOL MONOMERS; POLYALKYLENE GLCOLS; STABILIZER MIXTURE EASTMAN KODAK COMPANY (US) 1985-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11364710-B2 Composition, film, glass article, compound, high purity composition, method for producing compound, and method for producing film SOST, VCL, CCNO NPC1 3720/4885RAB9A 1907/4885SMN1; SMN2 2374/4885
US-20180311936-A1 COMPOSITION, FILM, GLASS ARTICLE, COMPOUND, HIGH PURITY COMPOSITION, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING FILM SOST, VCL, CCNO NPC1 3720/4885RAB9A 1907/4885SMN1; SMN2 2374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.